Caveolae and transcytosis in endothelial cells: role in atherosclerosis

被引:121
作者
Frank, Philippe G. [1 ,2 ,3 ,4 ]
Pavlides, Stephanos [1 ,2 ,3 ,4 ]
Lisanti, Michael P. [1 ,2 ,3 ,4 ]
机构
[1] Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Canc Biol, Philadelphia, PA 19107 USA
[2] Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Biochem, Philadelphia, PA 19107 USA
[3] Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Mol Biol, Philadelphia, PA 19107 USA
[4] Thomas Jefferson Univ, Stem Cell Biol & Regenerat Med Ctr, Philadelphia, PA 19107 USA
基金
美国国家卫生研究院;
关键词
Caveolin; Atherosclerosis; Lipoprotein; Cancer; Endothelium; BLOOD-BRAIN-BARRIER; TRANSENDOTHELIAL TRANSPORT; MICROVASCULAR HYPERPERMEABILITY; ALBUMIN; RECEPTOR; PERMEABILITY; BINDING; MICE; EXPRESSION; DEFECTS;
D O I
10.1007/s00441-008-0659-8
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The endothelium plays an important role in the regulation of molecular exchanges between the blood and peripheral tissues. The transport of molecules between tissues must be tightly controlled in order to maintain homeostasis between the different organs of the body. The endothelial transcytosis pathway has been shown to direct the transfer of proteins and solutes and therefore to act as a filtering system. This transport mode has been demonstrated to involve plasma-membrane vesicles that may be transferred with their cargo components from the apical to the basal side of endothelial cells. Among the vesicles implicated in the regulation of transcytosis, caveolae, which are 50 to 100-nm plasma-membrane invaginations, have been reported to play an essential part. In this paper, we review the function of caveolae and their major protein component (i.e., caveolin-1) in the regulation of endothelial transcytosis. The roles of caveolae in vascular diseases, such as atherosclerosis, are discussed.
引用
收藏
页码:41 / 47
页数:7
相关论文
共 58 条
[1]   Albumin, steroid hormones and the origin of vertebrates [J].
Baker, ME .
JOURNAL OF ENDOCRINOLOGY, 2002, 175 (01) :121-127
[2]   Uptake and transport of high-density lipoprotein (HDL) and HDL-associated α-tocopherol by an in vitro blood-brain barrier model [J].
Balazs, Z ;
Panzenboeck, U ;
Hammer, A ;
Sovic, A ;
Quehenberger, O ;
Malle, E ;
Sattler, W .
JOURNAL OF NEUROCHEMISTRY, 2004, 89 (04) :939-950
[3]   Targeting tumor stroma and exploiting mature tumor vasculature to improve anti-cancer drug delivery [J].
Bouzin, Caroline ;
Feron, Olivier .
DRUG RESISTANCE UPDATES, 2007, 10 (03) :109-120
[4]   TRANSCYTOTIC PATHWAY FOR BLOOD-BORNE PROTEIN THROUGH THE BLOOD-BRAIN BARRIER [J].
BROADWELL, RD ;
BALIN, BJ ;
SALCMAN, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (02) :632-636
[5]  
Cameron PL, 1997, J NEUROSCI, V17, P9520
[6]  
Chuang VTG, 2002, PHARM RES-DORDR, V19, P569
[7]   Caveolin-1 null mice develop cardiac hypertrophy with hyperactivation of p42/44 MAP kinase in cardiac fibroblasts [J].
Cohen, AW ;
Park, DS ;
Woodman, SE ;
Williams, TM ;
Chandra, M ;
Shirani, J ;
De Souza, AP ;
Kitsis, RN ;
Russell, RG ;
Weiss, LM ;
Tang, BY ;
Jelicks, LA ;
Factor, SM ;
Shtutin, V ;
Tanowitz, HB ;
Lisanti, MP .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2003, 284 (02) :C457-C474
[8]   A new function for the LDL receptor: Transcytosis of LDL across the blood-brain barrier [J].
Dehouck, B ;
Fenart, L ;
Dehouck, MP ;
Pierce, A ;
Torpier, G ;
Cecchelli, R .
JOURNAL OF CELL BIOLOGY, 1997, 138 (04) :877-889
[9]  
DEVRIES HE, 1993, J NEUROCHEM, V61, P1813
[10]   Analbuminemia produced by a novel splicing mutation [J].
Dolcini, Lorenzo ;
Caridi, Gianluca ;
Dagnino, Monica ;
Sala, Alberto ;
Goekce, Selim ;
Soekuecue, Semra ;
Campagnoli, Monica ;
Galliano, Monica ;
Minchiotti, Lorenzo .
CLINICAL CHEMISTRY, 2007, 53 (08) :1549-1552